Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
of neurodegenerative and neuromuscular disorders, including amyotrophic lateral sclerosis (ALS) and myotonic dystrophy (DM). Despite their importance in disease, the mechanisms through which repeat
-
and inflammatory eye diseases, pediatric ophthalmic conditions, and corneal dystrophies. The Genetic Counselor will collaborate with faculty and clinical teams to assess genetic risk, obtain and
-
. For more information see: https://medicine.iu.edu/faculty-labs/witczak Successful candidates will have recently completed PhD training, possess a strong background in type 2 diabetes, metabolism, and/or
-
. For more information see: https://medicine.iu.edu/faculty-labs/witczak Successful candidates will have recently completed PhD training, possess a strong background in type 2 diabetes, metabolism, and/or
-
assist/work on Stem Cell Regenerative Medicine to treat inherited dystrophies leading to blindness. diseases include retinitis pigmentosa, age-related macular degeneration, and Stargardt disease
-
University of Texas Health Science Center San Antonio | San Antonio, Texas | United States | 2 months ago
testing, and evaluating patients in ALS and MDA multidisciplinary clinics. We also have dozens of research studies in various neuromuscular disorders, including ALS, MG, CIDP, and muscular dystrophies
-
University of Texas Health Science Center San Antonio | San Antonio, Texas | United States | 2 months ago
(Muscular Dystrophy/ALS), Parkinson’s Disease and other movement disorders, multiple sclerosis, and stroke. The role will also include participation in clinical trials that are primarily neuromuscular-focused
-
, academic, and research support, and a busy clinical Neuromuscular program . The Neuromuscular multidisciplinary clinic is a Muscular Dystrophy Association (MDA) and ALS Association (ALSA) Care Center as
-
myopathies and congenital muscular dystrophies. Using a combinatorial approach that includes new gene discovery, model organism development, viral and non-viral gene therapies, and both targeted and large
-
therapies into clinical trials. They will also conduct research to help quantify the level of disease reversal the therapy provides in animal models for Duchenne muscular dystrophy. The Research Specialist B